Free Trial

Core Laboratories (CLB) Earnings Date, Estimates & Call Transcripts

Core Laboratories logo
$21.27 +0.15 (+0.71%)
(As of 11/22/2024 ET)

Core Laboratories Latest Earnings Summary

Upcoming Q4
Earnings Date
Jan. 29Estimated
Actual EPS
(Oct. 23)
$0.25 Beat By $0.04
Consensus EPS
(Oct. 23)
$0.21

Core Laboratories released Q3 2024 earnings on October 23, 2024, reporting an EPS of $0.25, which topped analysts' consensus estimates of $0.21 by $0.04. Quarterly revenue rose 7.2% year-over-year to $134.40 million, above analyst estimates of $134.16 million. With a trailing EPS of $0.65 and a P/E Ratio of 32.72, Core Laboratories' earnings are expected to grow 36.36% next year, from $0.77 to $1.05 per share.

CLB Upcoming Earnings

Core Laboratories' next earnings date is estimated for Wednesday, January 29, 2025, based off prior year's reporting schedules.

Get Core Laboratories Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Core Laboratories and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CLB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Core Laboratories Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.10$0.10$0.100.140 - 0.180
Q2 20241$0.16$0.16$0.160.190 - 0.230
Q3 20241$0.21$0.21$0.210.230 - 0.270
Q4 20241$0.22$0.22$0.220.200 - 0.250
FY 20244$0.69$0.69$0.69 
Q1 20251$0.19$0.19$0.19 
Q2 20251$0.27$0.27$0.27 
Q3 20251$0.33$0.33$0.33 
Q4 20251$0.33$0.33$0.33 
FY 20254$1.12$1.12$1.12 
Q1 20261$0.27$0.27$0.27 
Q2 20261$0.24$0.24$0.24 

Core Laboratories Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
1/29/2025
(Estimated)
------- 
10/23/2024Q3 2024$0.21$0.25+$0.04$0.29$134.16M$134.40M    
7/24/2024Q2 2024$0.21$0.22+$0.01$0.25$132.85M$130.58M      
4/24/2024Q1 2024$0.11$0.13+$0.02$0.19$124.47M$129.64M      
1/31/2024Q4 2023$0.20$0.19 -$0.01$0.24$127.80M$128.21M      
11/1/2023Q3 2023$0.23$0.22 -$0.01$0.25$129.81M$125.30M      
7/26/2023Q2 2023$0.15$0.23+$0.08-$0.02$132.20M$127.88M  
4/26/2023Q1 2023$0.14$0.08 -$0.06$0.11$126.26M$128.36M  
2/2/2023Q4 2022$0.19$0.20+$0.01$0.32$130.12M$127.57M      

Core Laboratories Earnings - Frequently Asked Questions

Core Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates. Learn more on CLB's earnings history.

Core Laboratories updated its fourth quarter earnings guidance on Wednesday, October, 23rd. The company provided EPS guidance of $0.20-0.25 for the period, compared to the consensus estimate of $0.24. The company issued revenue guidance of $128.5-135.5 million, compared to the consensus revenue estimate of $134.60 million.

In the previous quarter, Core Laboratories (NYSE:CLB) reported $0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $0.21 by $0.04. Learn more on analysts' earnings estimate vs. CLB's actual earnings.

The conference call for Core Laboratories's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Core Laboratories's latest earnings report can be read online.
Read Transcript

Core Laboratories (NYSE:CLB) has a recorded annual revenue of $522.82 million.

Core Laboratories (NYSE:CLB) has a recorded net income of $36.67 million. CLB has generated $0.65 earnings per share over the last four quarters.

Core Laboratories (NYSE:CLB) has a trailing price-to-earnings ratio of 32.72 and a forward price-to-earnings ratio of 27.62. The price/earnings-to-growth ratio is 1.38.

Core Laboratories's earnings are expected to grow from $0.77 per share to $1.05 per share in the next year, which is a 36.36% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:CLB) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners